Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 15 07 2021
accepted: 04 11 2021
revised: 27 10 2021
pubmed: 15 11 2021
medline: 9 4 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

Renal tumors are one of the most diverse groups of tumors in pathology. Many emerging and important entities have been described recently. Here, we describe a series of renal tumors occurring in adult patients, with distinct histologic features, and with a striking resemblance to gonadal sex cord-stromal tumors. Patients were three males and three females aged 39-82 years; tumor size ranged from 0.9 to 3.6 cm. Five tumors were organ-confined, while one case had a focal perinephric invasion. No aggressive behavior was noted. Microscopically, all the tumors were composed of loose or compact tubular structures with elongated or angulated shapes. The tumor cells were cylindrical or cuboidal, with pale eosinophilic cytoplasm, irregular nuclear membranes, and ISUP/WHO grade 2-3 nuclei. The stroma showed focal or prominent collagen deposition with prominent basement membrane-like material. In all cases, the tumor cells were positive for PAX8, CD10, and vimentin and retained positivity for FH and SDHB. Cathepsin K and AMACR were variably positive. Tumors were negative for HMB45, Melan A, TFE3, SF1, inhibin, calretinin, ER, PR, CD117, OCT3/4, SALL4, ALK, and WT1. Molecular studies showed no abnormalities in TFEB, TFE3, or FH genes. In 3/4 tested cases, mutation of the NF2 gene was present. In all the tested male cases, loss of the Y chromosome was found. In the relatively short follow-up, these tumors appear to have indolent behavior. This study expands the clinicopathologic diversity of renal cell tumors by describing a series of potentially novel tumors morphologically resembling gonadal sex-stromal tumors, with negativity for sex cord-stromal markers. Potential relationship to recently described biphasic hyalinizing psammomatous renal cell carcinoma is discussed.

Identifiants

pubmed: 34775513
doi: 10.1007/s00428-021-03235-x
pii: 10.1007/s00428-021-03235-x
doi:

Substances chimiques

Basic Helix-Loop-Helix Leucine Zipper Transcription Factors 0
Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-358

Subventions

Organisme : lékařská fakulta v plzni, univerzita karlova
ID : Q39
Organisme : research fund of university hospital plzen
ID : FNPl 00669806

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Moch H, Humphrey P, Ulbright T, et al (2016) editors WHO Classification Tumours of the Urinary System and Male Genital Organs. 4th ed
Trpkov K, Abou-Ouf H, Hes O et al (2017) Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity. Am J Surg Pathol 41(10):1299–1308
doi: 10.1097/PAS.0000000000000838
Trpkov K, Athanazio D, Magi-Galluzzi C et al (2018) Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases. Histopathology 72(5):777–785
doi: 10.1111/his.13432
Trpkov K, Williamson SR, Gao Y et al (2019) Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity? Histopathology 75(2):174–184
doi: 10.1111/his.13865
He H, Trpkov K, Martinek P et al (2018) “High-grade oncocytic renal tumor”: morphologic, immunohistochemical, and molecular genetic study of 14 cases. Virchows Arch 473(6):725–738
doi: 10.1007/s00428-018-2456-4
Trpkov K, Williamson SR, Gill AJ et al (2021) Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 34(6):1167–1184
doi: 10.1038/s41379-021-00737-6
Chen YB, Mirsadraei L, Jayakumaran G et al (2019) Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm. Am J Surg Pathol 43(1):121–131
doi: 10.1097/PAS.0000000000001170
Argani P, Reuter VE, Eble JN, et al (2020) Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations. Am J Surg Pathol 44(7):901–916
Yakirevich E, Pavlick DC, Perrino CM et al (2021) NF2 tumor suppressor gene inactivation in advanced papillary renal cell carcinoma. Am J Surg Pathol 45(5):716–718
doi: 10.1097/PAS.0000000000001586
Rogala J, Kojima F, Alaghehbandan R et al (2020) Papillary renal cell carcinoma with prominent spindle cell stroma - tumor mimicking mixed epithelial and stromal tumor of the kidney: clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 6 cases. Ann Diagn Pathol 44:151441
doi: 10.1016/j.anndiagpath.2019.151441
Chen YB, Xu J, Skanderup AJ et al (2016) Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nat Commun 7:13131
doi: 10.1038/ncomms13131
Sourbier C, Liao PJ, Ricketts CJ et al (2018) Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers. Oncotarget 9(12):10723–10733
doi: 10.18632/oncotarget.24112
Mehra R, Vats P, Cieslik M et al (2016) Biallelic alteration and dysregulation of the Hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney. Cancer Discov 6(11):1258–1266
doi: 10.1158/2159-8290.CD-16-0267
Wang J, Papanicolau-Sengos A, Chintala S et al (2016) Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. Oncotarget 7(21):29901–29915
doi: 10.18632/oncotarget.9093
Yoo NJ, Park SW, Lee SH (2012) Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias. Pathology 44(1):29–32
doi: 10.1097/PAT.0b013e32834c3599
Jiang F, Richter J, Schraml P et al (1998) Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol 153(5):1467–1473
doi: 10.1016/S0002-9440(10)65734-3
Kovacs G, Fuzesi L, Emanual A et al (1991) Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3(4):249–255
doi: 10.1002/gcc.2870030403
Scarcella S, Dell’Atti L, Galosi AB (2018) Renal germ cell metastatic tumour with rupture, bleeding and syncope: an unusual clinical presentation in a young patient. BMJ Case Rep. 2018
Kinney SN, Eble JN, Hes O et al (2015) Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma. Mod Pathol 28(9):1236–1248
doi: 10.1038/modpathol.2015.81
Md Zin R, Murch A, Charles A (2011) Pathology, genetics and cytogenetics of Wilms’ tumour. Pathology 43(4):302–312
doi: 10.1097/PAT.0b013e3283463575
Vujanic GM, Sandstedt B (2010) The pathology of Wilms’ tumour (nephroblastoma): the International Society of Paediatric Oncology approach. J Clin Pathol 63(2):102–109
doi: 10.1136/jcp.2009.064600

Auteurs

Gang Wang (G)

Department of Pathology, BC Cancer Vancouver, University of British Columbia, Vancouver, Canada.

Mahul B Amin (MB)

University of Tennessee Health Science Center, Memphis, TN, USA.

Petr Grossmann (P)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 304 60, Pilsen, Czech Republic.

Nikola Ptáková (N)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 304 60, Pilsen, Czech Republic.

Malcolm Hayes (M)

Department of Pathology, BC Cancer Vancouver, University of British Columbia, Vancouver, Canada.

Arndt Hartmann (A)

Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany.

Abbas Agaimy (A)

Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany.

Jose I Lopez (JI)

Department of Pathology, Cruces University Hospital Biocruces-Bizkaia Institute, University of the Basque Country (UPV/EHU), Leioa, Spain.

Michal Michal (M)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 304 60, Pilsen, Czech Republic.

Ondrej Hes (O)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Alej Svobody 80, 304 60, Pilsen, Czech Republic. hes@biopticka.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH